相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases? A Multi-institutional Analysis of 1497 Patients
Johan Gagniere et al.
ANNALS OF SURGERY (2020)
Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer
Jashodeep Datta et al.
CLINICAL CANCER RESEARCH (2020)
Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review
Georgios Antonios Margonis et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Mutation status and surgical selection
Georgios A. Margonis et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases
J. -B. Bachet et al.
BRITISH JOURNAL OF SURGERY (2019)
Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases
Yoshikuni Kawaguchi et al.
CLINICAL CANCER RESEARCH (2019)
Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients
Christelle de la Fouchardiere et al.
ONCOLOGIST (2019)
Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience
Benny Johnson et al.
ONCOLOGIST (2018)
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
Georgios Antonios Margonis et al.
JAMA SURGERY (2018)
Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer
Jeremy C. Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis
Federica Tosi et al.
CLINICAL COLORECTAL CANCER (2017)
Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases
Emmanouil Pikoulis et al.
ANTICANCER RESEARCH (2016)
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis
Francesco Passiglia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis
C. Cremolini et al.
ANNALS OF ONCOLOGY (2015)
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
M. Schirripa et al.
BRITISH JOURNAL OF CANCER (2015)
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
K. W. Brudvik et al.
BRITISH JOURNAL OF SURGERY (2015)
Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases
Qi Lin et al.
PLOS ONE (2014)
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy
Hao-Wei Teng et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
分享论文
